Download FREE Sample
Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Antibody Drug Conjugates (ADCs) Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
demand for targeted cancer therapies
- Growing investment in R&D for introducing new antibody-drug conjugates
- Increasing approvals by regulatory bodies such as the FDA and EMA for ADCs
- Restraints
- High development cost
- Stringent regulatory requirements that make the approval process lengthy and expensive
- Increasing competition from emerging therapies
- Opportunities
- Expansion into non-oncology indications
- Leveraging ADCs in combination with existing immunotherapies
- Rising demand for targeted therapies
- Key Market Trends
- Leveraging AI for target identification, drug design, and optimization of ADC properties
- Growing focus on patient-centric approaches
- Advancement in ADC manufacturing process
- Unmet Market Needs
- Industry Speaks
- Global Antibody Drug Conjze & Forecast (2023-2030), By Product USD Million
- Introduction
- Kadcyla
- Enhertu
- Adcetris
- Padcev
- Trodelvy
- Polivy
- Others
- Global Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), By Application USD Million
- Introduction
- Breast Cancer
- Blood Cancer
- Other Cancers
- Global Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), By Target USD Million
- Introduction
- HER2
- CD22
- CD30
- Others
- Global Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), By Technology USD Million
- Introduction
- Linker Type
- Cleavable Linker
- Non-cleavable Linker
- Linker less
-
- Payload Technology
- MMAE/ Auristatin
- Maytansinoids
- Camptothecin
- Others
- Payload Technology
- Global Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- US
- Europe Antibody Drug Conjugates (ADCs) Market Size &ecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast,
- Market Size & Forecast, By Technology (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Asia Pacific (APAC) Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & F & Forecast, By Technology (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- China
- Latin America (LATAM) Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Middle East & Africa (MEA) Antibody Drug Conjugates (ADCs) Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Target (USD Million)
- Market Size & Forecast, By Technology (USD Million)"10">
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Key Players and their Competitive Positioning
- Company Profiles*
- AbbVies
- Takeda Pharmaceutical Company Ltd.
- AstraZeneca PLC
- Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Mersana Therapeutics
- Gilead Sciences, Inc.
- Merck & Co.
- ADC Therapeutics SA
- Daiichi Sankyo Company Ltd.
- Other Prominent Players
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
Note: *Indicative list
**For listed companies<
